 |
 |
 |
 |
|
|
|
|
 |
|
|
 |
|
|
|
|
| |
|||||||||||||||||
|
|
|
|
|
|
|
|||||||||||
|
|||||||||||||||||
|
EID
Home | Ahead of Print | Past
Issues | EID Search | Contact
Us | Announcements | Suggested
Citation | Submit Manuscript
Volume 11, Number 4, April 2005 Antimicrobial-resistant Invasive Escherichia coli, SpainJesús Oteo,* Edurne Lázaro,† Francisco J. de Abajo,† Fernando Baquero,‡
José Campos,* and Spanish members of EARSS |
|
|
|
 |
|
| Back to article | |
|
Figure 2. Evolution of community quinolone consumption and prevalence of resistance to ciprofloxacin in invasive community-acquired Escherichia coli infections (European Antimicrobial Resistance Surveillance System–Spain 2001–2003). DDD, defined daily doses. 1, January–June; 2, July–December. |
|
|
|
|
|
EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z |
|
|
This page last reviewed March 14, 2005 |
|
|
Emerging
Infectious Diseases Journal |
|